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Dear Reader
As we approach the end of 2015, and mark the completion of the second volume of Drug Safety - Case Reports, the
editors and production staff at Adis wish to reflect on a successful year’s achievements and pay thanks to all those who
have contributed their time and effort to guarantee the exceptional quality of our content.
We are delighted to have seen the conclusion of formalities surrounding the joint venture between Springer
Science ? Business Media and Nature Publishing Group, Palgrave Macmillan, Macmillan Education in early May.
Substantial ground has already been made in the integration of business within the resulting Springer Nature company and
we at Adis look eagerly toward the future, as the benefits of the collective expertise and capabilities of this company carry
us forward.
The majority of our journals saw a rise in ISI impact factor against the previous year. Most notably, BioDrugs increased
by 41 % to 2.989; the European Journal of Drug Metabolism and Pharmacokinetics increased 19 % to 1.563; CNS Drugs
increased by 17 % to 5.113; Targeted Oncology increased 16 % to 4.000; Pediatric Drugs increased 15 % to 1.975; Drugs
& Aging increased 13 % to 2.838; and Molecular Diagnosis & Therapy increased a further 12 % to 2.891, having already
jumped 53 % in the preceding year. We hope to build upon these gains, once more, in 2016.
The Adis Book programme has grown substantially and 20 new titles will have been published over the course of the
year. Over 50 further titles are currently in development with leading academics, internationally, and we continue to add
more to the list. Our thanks, again, to all who have submitted these valuable proposals to date.
We offer our sincere thanks to all authors who have contributed articles to Drug Safety - Case Reports since the journal’s
launch in 2014. Their skill and dedication are critical to the continued publication of the journal. The world-class quality of
published articles is, similarly, testament to the significant efforts of the peer reviewers, whose commitment ensures that
our content is held to the highest possible standard. In addition to the members of our Honorary Editorial Board, we would
like to thank the following individuals who acted as reviewers for articles published in Drug Safety - Case Reports since the
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We hope that you have found the articles published in Drug Safety - Case Reports to be both interesting and informative.
The editors have appreciated the high quality of content contributed to the journal to date and look forward to keeping you
up to date with drug safety-related case reports and case series in the year to come.
With best wishes from the staff of Drug Safety - Case Reports and all at Adis Publications.
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